Intervention Review

Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy

  1. Tejasvi Chaudhari1,
  2. William McGuire2,*

Editorial Group: Cochrane Neonatal Group

Published Online: 11 JUL 2012

Assessed as up-to-date: 4 APR 2012

DOI: 10.1002/14651858.CD006817.pub3


How to Cite

Chaudhari T, McGuire W. Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy. Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD006817. DOI: 10.1002/14651858.CD006817.pub3.

Author Information

  1. 1

    John Hunter Children's Hospital, New Lambton, Australia

  2. 2

    Hull York Medical School & Centre for Reviews and Dissemination, University of York, York, Y010 5DD, UK

*William McGuire, Hull York Medical School & Centre for Reviews and Dissemination, University of York, York, Y010 5DD, UK. William.McGuire@hyms.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 11 JUL 2012

SEARCH

Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
    http://wiley.force.com/Interface/ContactJournalCustomerServices_V2.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.